Treatment with a gonadotrophin releasing hormone agonist before hysterectomy for leiomyomas: results of a multicentre, randomised controlled trial
Articolo
Data di Pubblicazione:
1998
Citazione:
Treatment with a gonadotrophin releasing hormone agonist before hysterectomy for leiomyomas: results of a multicentre, randomised controlled trial / P. Vercellini, P. G. Crosignani, C. Mangioni, E. Imparato, A. Ferrari, O. De Giorgi. - In: BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY. - ISSN 0306-5456. - 105:11(1998 Nov), pp. 1148-1154. [10.1111/j.1471-0528.1998.tb09967.x]
Abstract:
To ascertain whether uterine shrinkage induced by a gonadotrophin releasing hormone agonist before hysterectomy for fibroids increases the possibility of a vaginal procedure.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Antineoplastic Agents, Hormonal; Leiomyomatosis; Triptorelin Pamoate; Combined Modality Therapy; Humans; Prospective Studies; Hysterectomy; Delayed-Action Preparations; Adult; Treatment Outcome; Uterine Neoplasms; Middle Aged; Female
Elenco autori:
P. Vercellini, P.G. Crosignani, C. Mangioni, E. Imparato, A. Ferrari, O. De Giorgi
Link alla scheda completa: